Fibrinolysins Screening Interpretation and Report Priced at $90 at Aurora Burlington, WI

The Fibrinolysins Screening Interpretation and Report, priced at $90 at Aurora Burlington, WI, is a specialized blood test designed to evaluate the activity of fibrinolysins—enzymes vital for breaking down blood clots. This screening is essential for individuals with a history or symptoms of clotting or bleeding disorders, as it aids in diagnosing and managing these conditions by offering a detailed interpretation of the fibrinolytic system. The $90 fee typically includes blood sample analysis, interpretation by qualified medical personnel, and a comprehensive report. For greater transparency and to avoid unexpected charges, patients are advised to request an itemized estimate and clarify what is included in the quoted fee.

Cost Breakdown

• Blood sample collection and processing: Included in the $90 fee
• Interpretation of results by a medical professional: Included
• Comprehensive written report: Included
• Additional services (e.g., follow-up consultations, further diagnostic tests): Not included; may incur extra charges

Associated Costs

• Follow-up appointments to discuss results
• Additional laboratory tests if abnormal results are found
• Consultations with specialists (e.g., hematologists)
• Treatment costs if a clotting or bleeding disorder is diagnosed

Insurance & Payment Advice

• Check with your health insurance provider to determine if the Fibrinolysins Screening is covered under your plan.
• Ask Aurora Medical Center Burlington for a detailed, itemized bill for transparency.
• Inquire about payment plans or financial assistance if you are uninsured or underinsured.

Frequently Asked Questions

• What is the Fibrinolysins Screening Interpretation and Report?
  This is a specialized laboratory analysis that measures the activity of fibrinolysins in your blood, helping to assess your risk for clotting or bleeding disorders.
• Who should consider this screening?
  Individuals with a history of abnormal blood clotting, unexplained bleeding, or those with symptoms suggesting clotting disorders should consider this test.
• What does the $90 fee include?
  The fee covers blood sample collection, laboratory analysis, interpretation by a healthcare professional, and a detailed report.
• Are there any additional costs I should expect?
  Additional charges may apply for follow-up appointments, further diagnostic tests, or treatment if an abnormality is detected.
• Will my insurance cover this screening?
  Coverage varies by insurance plan. Contact your insurance provider before the test to verify coverage and potential out-of-pocket costs.
• How should I prepare for this screening?
  Most patients do not require special preparation, but you should follow any instructions provided by your healthcare provider.
• When will I receive my results?
  Turnaround times can vary, but most patients receive their results within a few days to a week after the test.
• What do abnormal results mean?
  Abnormal results may indicate an underlying clotting or bleeding disorder, and your healthcare provider will recommend further evaluation or treatment as needed.
• Can I request an itemized bill?
  Yes, you should request an itemized bill to understand all charges associated with your screening.
• Is this test available at other locations or only at Aurora Burlington?
  While this excerpt refers to Aurora Burlington, similar screenings may be available at other medical centers; ask your provider for options.
• What should I do if I cannot afford the screening?
  Ask the medical center about financial assistance programs, sliding scale fees, or payment plans.

Aurora Medical Center Burlington offers a Fibrinolysins Screening Interpretation and Report service, priced at $90, which involves analyzing blood samples to assess the activity of fibrinolysins, enzymes that help break down blood clots. This screening is crucial for diagnosing and managing conditions related to abnormal clotting or bleeding disorders, providing valuable insights into a patient’s fibrinolytic system. The cost of $90 reflects the comprehensive nature of the interpretation and report, ensuring that patients receive detailed and accurate information about their fibrinolytic health.

What is the purpose of the Fibrinolysins Screening Interpretation and Report? – The purpose of this screening is to evaluate the activity of fibrinolysins in the blood, which are enzymes responsible for breaking down blood clots, helping diagnose and manage clotting or bleeding disorders.

Who should consider getting a Fibrinolysins Screening? – Individuals with a history of clotting or bleeding disorders, or those experiencing unexplained symptoms related to these conditions, should consider this screening for a better understanding of their fibrinolytic system.

What does the $90 cost cover? – The $90 cost covers the analysis of the blood sample, the interpretation of the results by medical professionals, and a detailed report that provides insights into the patient’s fibrinolytic activity.

How is the screening performed? – The screening involves drawing a blood sample from the patient, which is then analyzed in a laboratory to measure the activity of fibrinolysins, followed by a professional interpretation of the results.

How long does it take to receive the results? – Typically, results are available within a few days after the blood sample is taken, allowing for timely diagnosis and management of any identified issues.

Are there any risks associated with the screening? – The screening is a standard blood test with minimal risks, primarily limited to slight discomfort or bruising at the site of the blood draw.

Can this screening be covered by insurance? – Coverage for the Fibrinolysins Screening Interpretation and Report may vary depending on the patient’s insurance plan, so it is advisable to check with the insurance provider beforehand.

Why is it important to understand fibrinolytic activity? – Understanding fibrinolytic activity is crucial for identifying potential risks of excessive clotting or bleeding, enabling healthcare providers to tailor treatment plans accordingly.